**Fluvoxamine is used in Europe and Canada for depression; it is currently only approved for OCD in the U.S. 每两周减少25毫克直到剂量为25毫克/天,然后每两周减少12.5毫克。 *对于郁复伸缓释片,每两周减少37.5毫克剂量。 **氟伏沙明在欧洲和加拿大被批准用于治疗抑郁症;目前它在美国仅被批准用于治疗...
In addition to treating depression, selective serotonin reuptake inhibitors (SSRIs) have been medically approved for the treatment of other conditions like generalized anxiety disorder (GAD), bulimia, fibromyalgia, hot flashes, obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress ...
OCDWhen fluoxetine, the first of the presently used serotonin-specific reuptake inhibitors (SSRIs), was approved in 1987, two effects of the drug had been established: inhibition of serotonin reuptake by the serotonin transporter (SERT), and partial displacement of serotonin binding to cultured ...
Female mice only were used because of smaller and less varying size, allowing for higher 5-HTP SR dose, given fixed minipump capacity (see below). Experiments were conducted in accordance with the National Institutes of Health guidelines for the care and use of animals and an approved protocol...
In fact, a number of 5-HT1A agonists are currently undergoing various phases of clinical studies or have already been approved for marketing. Their pharmacological activity is not limited to the treatment of depression, but may also be used in the treatment of anxiety (osemozotan, phase II),...